DIMA Biotechnology Ltd.'s Anti-CB1 (nimacimab biosimilar)mAb is a Human monoclonal antibody. The Anti-CB1 (nimacimab biosimilar)mAb Antibody was generated using CNR1 as the antigen. It reacts with Human. This antibody has been shown to work in applications such as: Flow Cytometry.